Neola Medical AB (OSTO:NEOLA) Gross-Profit-to-Asset % : 12.66% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Neola Medical AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Neola Medical AB's annualized Gross Profit for the quarter that ended in Mar. 2024 was kr10.70 Mil. Neola Medical AB's average Total Assets over the quarter that ended in Mar. 2024 was kr84.55 Mil. Therefore, Neola Medical AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 12.66%.

Neola Medical AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Neola Medical AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neola Medical AB Gross-Profit-to-Asset % Chart

Neola Medical AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

14.10

8.05

25.94

13.46

9.94

Neola Medical AB Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															10.62	11.64	9.10	12.47	12.66

Competitive Comparison of Neola Medical AB's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Neola Medical AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's Gross-Profit-to-Asset % falls into.

Neola Medical AB Gross-Profit-to-Asset % Calculation

Neola Medical AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	8.019	/	( (75.33	+	86.018)	/ 2 )
	=	8.019	/	80.674
	=	9.94 %

Neola Medical AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	10.7	/	( (86.018	+	83.074)	/ 2 )
	=	10.7	/	84.546
	=	12.66 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Neola Medical AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neola Medical AB (OSTO:NEOLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neola Medical AB (OSTO:NEOLA) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevägen 27, Ideon Science Park, Lund, SWE, 223 63

Website

https://www.neolamedical.se

Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.

Neola Medical AB (OSTO:NEOLA) Headlines

No Headlines